Factors Associated with Thyroid-Related Adverse Events in Patients Receiving PD-1 or PD-L1 Inhibitors Using Machine Learning Models

Targets of immune checkpoint inhibitors (ICIs) regulate immune homeostasis and prevent autoimmunity by downregulating immune responses and by inhibiting T cell activation. Although ICIs are widely used in immunotherapy because of their good clinical efficacy, they can also induce autoimmune-related...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Woorim Kim, Young-Ah Cho, Dong-Chul Kim, A-Ra Jo, Kyung-Hyun Min, Kyung-Eun Lee
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/e347eae95b294156992d3457b0c3abe9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e347eae95b294156992d3457b0c3abe9
record_format dspace
spelling oai:doaj.org-article:e347eae95b294156992d3457b0c3abe92021-11-11T15:33:35ZFactors Associated with Thyroid-Related Adverse Events in Patients Receiving PD-1 or PD-L1 Inhibitors Using Machine Learning Models10.3390/cancers132154652072-6694https://doaj.org/article/e347eae95b294156992d3457b0c3abe92021-10-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/21/5465https://doaj.org/toc/2072-6694Targets of immune checkpoint inhibitors (ICIs) regulate immune homeostasis and prevent autoimmunity by downregulating immune responses and by inhibiting T cell activation. Although ICIs are widely used in immunotherapy because of their good clinical efficacy, they can also induce autoimmune-related adverse events. Thyroid-related adverse events are frequently associated with anti-programmed cell death 1 (PD-1) or anti-programmed cell death-ligand 1 (PD-L1) agents. The present study aims to investigate the factors associated with thyroid dysfunction in patients receiving PD-1 or PD-L1 inhibitors and to develop various machine learning approaches to predict complications. A total of 187 patients were enrolled in this study. Logistic regression analysis was conducted to investigate the association between such factors and adverse events. Various machine learning methods were used to predict thyroid-related complications. After adjusting for covariates, we found that smoking history and hypertension increase the risk of thyroid dysfunction by approximately 3.7 and 4.1 times, respectively (95% confidence intervals (CIs) 1.338–10.496 and 1.478–11.332, <i>p</i> = 0.012 and 0.007). In contrast, patients taking opioids showed an approximately 4.0-fold lower risk of thyroid-related complications than those not taking them (95% CI 1.464–11.111, <i>p</i> = 0.007). Among the machine learning models, random forest showed the best prediction, with an area under the receiver operating characteristic of 0.770 (95% CI 0.648–0.883) and an area under the precision-recall of 0.510 (95%CI 0.357–0.666). Hence, this study utilized various machine learning models for prediction and showed that factors such as smoking history, hypertension, and opioids are associated with thyroid-related adverse events in cancer patients receiving PD-1/PD-L1 inhibitors.Woorim KimYoung-Ah ChoDong-Chul KimA-Ra JoKyung-Hyun MinKyung-Eun LeeMDPI AGarticleimmune checkpoint inhibitorsrisk factorshyperthyroidismhypothyroidismmachine learningNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5465, p 5465 (2021)
institution DOAJ
collection DOAJ
language EN
topic immune checkpoint inhibitors
risk factors
hyperthyroidism
hypothyroidism
machine learning
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle immune checkpoint inhibitors
risk factors
hyperthyroidism
hypothyroidism
machine learning
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Woorim Kim
Young-Ah Cho
Dong-Chul Kim
A-Ra Jo
Kyung-Hyun Min
Kyung-Eun Lee
Factors Associated with Thyroid-Related Adverse Events in Patients Receiving PD-1 or PD-L1 Inhibitors Using Machine Learning Models
description Targets of immune checkpoint inhibitors (ICIs) regulate immune homeostasis and prevent autoimmunity by downregulating immune responses and by inhibiting T cell activation. Although ICIs are widely used in immunotherapy because of their good clinical efficacy, they can also induce autoimmune-related adverse events. Thyroid-related adverse events are frequently associated with anti-programmed cell death 1 (PD-1) or anti-programmed cell death-ligand 1 (PD-L1) agents. The present study aims to investigate the factors associated with thyroid dysfunction in patients receiving PD-1 or PD-L1 inhibitors and to develop various machine learning approaches to predict complications. A total of 187 patients were enrolled in this study. Logistic regression analysis was conducted to investigate the association between such factors and adverse events. Various machine learning methods were used to predict thyroid-related complications. After adjusting for covariates, we found that smoking history and hypertension increase the risk of thyroid dysfunction by approximately 3.7 and 4.1 times, respectively (95% confidence intervals (CIs) 1.338–10.496 and 1.478–11.332, <i>p</i> = 0.012 and 0.007). In contrast, patients taking opioids showed an approximately 4.0-fold lower risk of thyroid-related complications than those not taking them (95% CI 1.464–11.111, <i>p</i> = 0.007). Among the machine learning models, random forest showed the best prediction, with an area under the receiver operating characteristic of 0.770 (95% CI 0.648–0.883) and an area under the precision-recall of 0.510 (95%CI 0.357–0.666). Hence, this study utilized various machine learning models for prediction and showed that factors such as smoking history, hypertension, and opioids are associated with thyroid-related adverse events in cancer patients receiving PD-1/PD-L1 inhibitors.
format article
author Woorim Kim
Young-Ah Cho
Dong-Chul Kim
A-Ra Jo
Kyung-Hyun Min
Kyung-Eun Lee
author_facet Woorim Kim
Young-Ah Cho
Dong-Chul Kim
A-Ra Jo
Kyung-Hyun Min
Kyung-Eun Lee
author_sort Woorim Kim
title Factors Associated with Thyroid-Related Adverse Events in Patients Receiving PD-1 or PD-L1 Inhibitors Using Machine Learning Models
title_short Factors Associated with Thyroid-Related Adverse Events in Patients Receiving PD-1 or PD-L1 Inhibitors Using Machine Learning Models
title_full Factors Associated with Thyroid-Related Adverse Events in Patients Receiving PD-1 or PD-L1 Inhibitors Using Machine Learning Models
title_fullStr Factors Associated with Thyroid-Related Adverse Events in Patients Receiving PD-1 or PD-L1 Inhibitors Using Machine Learning Models
title_full_unstemmed Factors Associated with Thyroid-Related Adverse Events in Patients Receiving PD-1 or PD-L1 Inhibitors Using Machine Learning Models
title_sort factors associated with thyroid-related adverse events in patients receiving pd-1 or pd-l1 inhibitors using machine learning models
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/e347eae95b294156992d3457b0c3abe9
work_keys_str_mv AT woorimkim factorsassociatedwiththyroidrelatedadverseeventsinpatientsreceivingpd1orpdl1inhibitorsusingmachinelearningmodels
AT youngahcho factorsassociatedwiththyroidrelatedadverseeventsinpatientsreceivingpd1orpdl1inhibitorsusingmachinelearningmodels
AT dongchulkim factorsassociatedwiththyroidrelatedadverseeventsinpatientsreceivingpd1orpdl1inhibitorsusingmachinelearningmodels
AT arajo factorsassociatedwiththyroidrelatedadverseeventsinpatientsreceivingpd1orpdl1inhibitorsusingmachinelearningmodels
AT kyunghyunmin factorsassociatedwiththyroidrelatedadverseeventsinpatientsreceivingpd1orpdl1inhibitorsusingmachinelearningmodels
AT kyungeunlee factorsassociatedwiththyroidrelatedadverseeventsinpatientsreceivingpd1orpdl1inhibitorsusingmachinelearningmodels
_version_ 1718435215096938496